Table 1 Clinico-pathological variables for the patient cohort (n = 220).
Clinico-pathological parameter | n (%) |
|---|---|
Age | |
Median | 46.3 |
Range | 13.0–90.0 |
Gender | |
Male | 102 (46.4) |
Female | 118 (53.6) |
Histological subtype | |
Adenocarcinoma | 190 (86.4) |
Mucinous carcinoma | 30 (13.6) |
Histological grade | |
Well differentiated | 24 (10.9) |
Moderately differentiated | 152 (69.1) |
Poorly differentiated | 39 (17.7) |
Unknown | 5 (2.3) |
Tumor site | |
Left | 167 (75.9) |
Right | 53 (24.1) |
pT | |
T1 | 7 (3.2) |
T2 | 22 (10.0) |
T3 | 152 (69.1) |
T4 | 29 (13.2) |
Unknown | 10 (4.5) |
pN | |
N0 | 104 (47.3) |
N1 | 63 (28.6) |
N2 | 42 (19.1) |
Nx | 11 (5.0) |
pM | |
M0 | 181 (82.3) |
M1 | 39 (17.7) |
TNM stage | |
I | 26 (11.8) |
II | 75 (34.1) |
III | 79 (35.9) |
IV | 39 (17.7) |
Unknown | 1 (0.5) |
MMR status | |
dMMR | 73 (33.2) |
pMMR | 147 (66.8) |
